Ways to help
About us
Contact Us
Home >
Feb 2017
Trish Foundation contributes to first-ever discovery
Jun 2017
Researchers funded by the Trish Foundation making great progress
Dec 2017
Announcement by NHMRC
Jan 2018
2018 Round of Funding Four new Projects announced
Jun 2018
Exciting regrowth of nerve fibres
Jun 2018
Dr Merson secures $1 million from NHMRC
Jun 2018
Findings submitted for publication
Jan 2019
New Research Projects commencing 2019 announced

PrevANZ Vitamin D MS Prevention Trial

Update November 2018

PrevANZ is a world-first clinical trial that will test whether oral vitamin D supplementation can prevent MS in those at high risk of developing the disease.

Funded by MS Research Australia with the support of many generous donors, including the Trish MS Research Foundation, this gold-standard clinical trial aims to resolve the unanswered question of whether vitamin D supplementation is effective to prevent a diagnosis of MS following a person’s first clinical ‘attack’ suggestive of MS.

This is an area in which the expertise in Australia and New Zealand is second to none and PrevANZ represents an unequaled opportunity to have a major impact in the prevention and better treatment of MS globally.

The trial has now enrolled 179 participants, a milestone of 75% of the target of 240. All aspects of patients’ participation in the trial are running smoothly, with no safety concerns currently emerging. As a ‘double-blind’ trial where doctors and patients are unaware of the dose delivered to each patient, it is not yet possible to provide any early indication of the effects of vitamin D supplementation.

The PrevANZ team are continuing to work closely with the medical community to promote the ongoing trial and maximise recruitment for a successful conclusion to the trial with results anticipated in 2020. 

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.